SVB Securities cut shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) from an outperform rating to a market perform rating in a research note released on Tuesday morning, The Fly reports. CTIC has been the topic of several other reports. JMP Securities downgraded shares of CTI BioPharma from an outperform rating to a market perform […]